Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07690852 · ClinicalTrials.gov registry record
Environmental Exposure Assessment in High-Risk and Early-Onset Breast Cancer Care
A clinical trial, sponsored by City of Hope Medical Center.
- Not yet
- Registry status
- 423
- Enrollment target
NCT07690852: Clinical Trial study, sponsored by City of Hope Medical Center.
NCT07690852 is a clinical trial that has not yet begun recruiting, run by City of Hope Medical Center. The registered enrollment target is 423 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07690852 has not yet begun recruiting, sponsored by City of Hope Medical Center.
- NOT YET RECRUITING
- Registry status
- 423 participants
- Enrollment target
Study Summary
This study evaluates patient and provider attitudes about environmental exposure risk assessments into clinical care for female patients at average or high risk for breast cancer and/or diagnosed with early onset breast cancer.
Primary Outcome
Will compare emotional responses, environmental health literacy, compensatory health behaviors, and cancer fatalism across the three participant groups (average risk, high risk, and early onset) using analysis of covariance (ANCOVA). Emotional response scores will be constructed by summing items within the positive and negative subscales separately, while the environmental health literacy, compensatory health behaviors and cancer fatalism will be calculated as summed total scores. ANCOVA will be
Interventions
- OTHER Non-Interventional Study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 423 participants |
| Start Date | 2026-12-28 |
| Est. Completion | 2028-01-01 |
What is known before NCT07690852 opens enrollment
NCT07690852 is an observational study that tracks outcomes without assigning an intervention. The registered 423 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Non-Interventional Study is the first listed.
NCT07690852 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07690852 about?
NCT07690852 is a clinical study titled "Environmental Exposure Assessment in High-Risk and Early-Onset Breast Cancer Care". This study evaluates patient and provider attitudes about environmental exposure risk assessments into clinical care for female patients at average or high risk for breast cancer and/or diagnosed with early onset breast cancer.
What is the current status of trial NCT07690852?
This trial is currently not yet recruiting. The enrollment target is 423 participants. The study started on 2026-12-28. Estimated completion is 2028-01-01.
What interventions are being tested in trial NCT07690852?
The interventions under investigation include: Non-Interventional Study (OTHER).
Who is sponsoring clinical trial NCT07690852?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06935591 · 423 participants · NA
Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study
- NCT07128628 · 423 participants · Phase 2
A Study Evaluating the Safety and Efficacy of a Fixed-Dose Combination for Dry Eye Disease
- NCT05632770 · 424 participants · NA
A Deployment Focused Pragmatic Trial of Optimal Stepped Care Intervention Targeting PTSD and Comorbidity for Acutely Hospitalized Injury Survivors Treated in US Trauma Care Systems
- NCT05733767 · 424 participants · Phase 2
Smoking Cessation Pharmacotherapy-Nurse Practitioner Led Tobacco Treatment Team Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI